The American Association for Cancer Research exhibit hall debuted the new LiquidBiopsy™ Platform, and in this video Vidya Venkatesh (Thermo Fisher Scientific) shares the advantages of this system.
From collection and stabilization to excellent recovery and downstream analysis this system isolates both cell-free DNA (cfDNA) and circulating tumor cells (CTCs) from a single whole-blood sample.
More information about the LiquidBiopsy Platform is available online.
Optimizing multiplex qPCR: How to amplify up to 6 targets without compromising analytical sensitivity
What happens when a multiplex qPCR assay begins to lose perf...
Read More
From Discovery to Monitoring: How Sequencing and PCR Work Together in Oncology Research
Scientific, joins the Absolute Gene-ius podcast to discuss h...
Read More
qPCR-based fragmentomics for monitoring cancer disease progression
As fragmentomics gains momentum in cancer liquid biopsy rese...
Read More
Unlocking Cancer’s Genetic Secrets with Digital PCR
In this episode of Absolute Gene-ius, we explore how digital...
Read More
Leave a Reply